Log in

NASDAQ:EKSO - Ekso Bionics Stock Price, Forecast & News

$0.36
-0.02 (-5.19 %)
(As of 01/19/2020 02:08 AM ET)
Add
Compare
Today's Range
$0.36
Now: $0.37▼
$0.39
50-Day Range
$0.35
MA: $0.45▼
$0.58
52-Week Range
$0.35
Now: $0.37▼
$2.55
Volume1.38 million shs
Average Volume1.47 million shs
Market Capitalization$27.36 million
P/E RatioN/A
Dividend YieldN/A
Beta1.44
Ekso Bionics Holdings, Inc designs, develops, and sells exoskeletons for use in the healthcare, industrial, and military markets in North America, Europe, the Middle East, and Africa. The company operates through EksoHealth and EksoWorks segments. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries and hemiplegia due to stroke. Read More…

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry General industrial machinery,
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:EKSO
Previous SymbolOTCMKTS:EKSOD
CUSIPN/A
CIK1549084
Webhttp://www.eksobionics.com/
Phone510-984-1761

Debt

Debt-to-Equity Ratio0.28
Current Ratio2.11
Quick Ratio1.69

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$11.33 million
Price / Sales2.41
Cash FlowN/A
Price / Cash FlowN/A
Book Value$0.04 per share
Price / Book9.13

Profitability

EPS (Most Recent Fiscal Year)($0.44)
Net Income$-26,990,000.00
Net Margins-100.36%
Return on Equity-376.63%
Return on Assets-85.18%

Miscellaneous

Employees77
Outstanding Shares74,950,000
Market Cap$27.36 million
Next Earnings Date2/27/2020 (Estimated)
OptionableNot Optionable

Receive EKSO News and Ratings via Email

Sign-up to receive the latest news and ratings for EKSO and its competitors with MarketBeat's FREE daily newsletter.

NASDAQ:EKSO Rates by TradingView

(Ad)


A devastating technical glitch could crush the next generation of wireless technology before it even launches. With trillions of dollars and millions of jobs at stake, one company with the "5G fix" could put as much as $234,770 in your pocket this year. But Wall Street vultures are circling... you'll need to move quickly or risk missing this $5 bargain.

Ekso Bionics (NASDAQ:EKSO) Frequently Asked Questions

What is Ekso Bionics' stock symbol?

Ekso Bionics trades on the NASDAQ under the ticker symbol "EKSO."

When did Ekso Bionics' stock split? How did Ekso Bionics' stock split work?

Ekso Bionics shares reverse split before market open on Thursday, May 5th 2016. The 1-7 reverse split was announced on Wednesday, May 4th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, May 4th 2016. An investor that had 100 shares of Ekso Bionics stock prior to the reverse split would have 14 shares after the split.

How were Ekso Bionics' earnings last quarter?

Ekso Bionics Holdings Inc (NASDAQ:EKSO) posted its quarterly earnings data on Wednesday, October, 30th. The company reported ($0.06) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.07) by $0.01. The business had revenue of $3.32 million for the quarter. Ekso Bionics had a negative return on equity of 376.63% and a negative net margin of 100.36%. View Ekso Bionics' Earnings History.

When is Ekso Bionics' next earnings date?

Ekso Bionics is scheduled to release their next quarterly earnings announcement on Thursday, February 27th 2020. View Earnings Estimates for Ekso Bionics.

What guidance has Ekso Bionics issued on next quarter's earnings?

Ekso Bionics issued an update on its FY 2019 Pre-Market earnings guidance on Friday, January, 10th. The company provided EPS guidance of for the period. The company issued revenue guidance of $13.9-13.9 million, compared to the consensus revenue estimate of $13.77 million.

What price target have analysts set for EKSO?

3 equities research analysts have issued 1-year price targets for Ekso Bionics' stock. Their forecasts range from $1.00 to $2.90. On average, they anticipate Ekso Bionics' stock price to reach $1.70 in the next twelve months. This suggests a possible upside of 365.8% from the stock's current price. View Analyst Price Targets for Ekso Bionics.

What is the consensus analysts' recommendation for Ekso Bionics?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ekso Bionics in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Ekso Bionics.

What are Wall Street analysts saying about Ekso Bionics stock?

Here are some recent quotes from research analysts about Ekso Bionics stock:
  • 1. According to Zacks Investment Research, "Ekso Bionics Holdings, Inc. is engaged in designing, developing and selling wearable robots or exoskeletons for the medical, military, industrial and consumer markets. The company's operating segment consists of Engineering Services and Medical segments. It operates primarily in North America, Western Europe, the Middle East and South Africa. Ekso Bionics Holdings, Inc. is headquartered in Richmond, California. " (12/30/2019)
  • 2. Aegis analysts commented, "We think conversion rate is an interesting metric to follow as it is representative of accounts which trialed the Ekso GT via the rental program, and then decided to make the capital commitment, which is significant, at around $130K per Ekso GT." (8/8/2019)

Has Ekso Bionics been receiving favorable news coverage?

Headlines about EKSO stock have trended somewhat negative on Sunday, InfoTrie Sentiment Analysis reports. InfoTrie ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Ekso Bionics earned a media sentiment score of -1.4 on InfoTrie's scale. They also gave media stories about the company a news buzz of 1.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Ekso Bionics.

Who are some of Ekso Bionics' key competitors?

What other stocks do shareholders of Ekso Bionics own?

Who are Ekso Bionics' key executives?

Ekso Bionics' management team includes the folowing people:
  • Mr. Steven A. Sherman, Exec. Chairman (Age 73)
  • Mr. Jack Peurach, Pres, CEO & Director (Age 53)
  • Mr. John F. Glenn, CFO & Sec. (Age 57)
  • Mr. William Shaw, Chief Commercial Officer (Age 45)
  • Ms. Foon Lim Chwee, Pres of APAC

How do I buy shares of Ekso Bionics?

Shares of EKSO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Ekso Bionics' stock price today?

One share of EKSO stock can currently be purchased for approximately $0.37.

How big of a company is Ekso Bionics?

Ekso Bionics has a market capitalization of $27.36 million and generates $11.33 million in revenue each year. The company earns $-26,990,000.00 in net income (profit) each year or ($0.44) on an earnings per share basis. Ekso Bionics employs 77 workers across the globe.View Additional Information About Ekso Bionics.

What is Ekso Bionics' official website?

The official website for Ekso Bionics is http://www.eksobionics.com/.

How can I contact Ekso Bionics?

Ekso Bionics' mailing address is 1414 HARBOUR WAY SOUTH SUITE 1201, RICHMOND CA, 94804. The company can be reached via phone at 510-984-1761 or via email at [email protected]


MarketBeat Community Rating for Ekso Bionics (NASDAQ EKSO)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  274 (Vote Outperform)
Underperform Votes:  234 (Vote Underperform)
Total Votes:  508
MarketBeat's community ratings are surveys of what our community members think about Ekso Bionics and other stocks. Vote "Outperform" if you believe EKSO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EKSO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/19/2020 by MarketBeat.com Staff

Featured Article: What is a stock portfolio tracker?
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel